Calcium Channel Blockade in Primary Aldosteronism

Clinical trial NCT04179019 · COMPLETED

Trial details

NCT number: NCT04179019
Sponsor: Brigham and Women's Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Aldosteronism Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)

Start date: 2020-09-01
Primary completion: 2023-12-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.